Báo cáo y học: "Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock"

Báo cáo khoa học: "Drotrecogin alfa (activated): down and not out, but not really in eithe"

2 p | 63 | 7

Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death"

1 p | 55 | 6

Báo cáo y học: "Drotrecogin alfa (activated): real-life use and outcomes for the UK"

12 p | 43 | 5

Báo cáo khoa học: "Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death"

2 p | 57 | 5

Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies"

13 p | 51 | 5

Báo cáo y học: "Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy"

6 p | 80 | 4

Báo cáo y học: "Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)"

11 p | 83 | 4

Báo cáo khoa học: "Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis"

2 p | 35 | 3

Báo cáo y học: "Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism."

10 p | 50 | 3